Pandemics

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years,…

Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency’s regulatory activities in…

A study revealed that Jun13296, a novel PLpro inhibitor, demonstrates potent antiviral and anti-inflammatory effects in vivo, offering hope for future COVID-19…

A groundbreaking preclinical study reveals how targeting a viral enzyme with a new drug could prevent long-COVID complications, offering hope…